Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of an Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient is between the ages of 18 and 80.~2. Major depressive disorder or depressive disorder not otherwise specified as ascertained by a physician or mental health professional licensed to diagnose.~3. Patient is an outpatient and not in imminent need of inpatient hospitalization, or a discharging inpatient with scheduled follow-up with a Behavioral Health psychiatrist.~4. Patient has been referred to see a psychiatrist for optimum medication management.~5. Patient's Hamilton Depression Rating score is \>14~6. Ability to read, understand and sign an informed consent document~Exclusion Criteria:~1. Serious medical illness (as ascertained via the initial triage screening process)~2. Patients with a diagnosis of Bipolar I disorder~3. Patients with a diagnosis of Schizophrenia or Schizoaffective disorder~4. Patients who are legally unable to consent to enrollment in the study (i.e. patients with legal guardians)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Guided (Type: EXPERIMENTAL): A pharmacogenomic algorithm (GeneSight) guided treatment decisions for antidepressant medication selection and appropriate dosing.
- Unguided (Type: NO_INTERVENTION): Treatment as usual

Based on this trial design, predict the completion outcome and termination type (if applicable).